So, that would rely on adequately sampling the population of interest to parameterize the distribution. The report I linked to has some of that detail, but I don't know of any studies that have the rigor needed to get you what you're seeking. As I said, the threshold values are functionally based, not statistically defined, so I don't know if anyone's ever gone looking for the nature of the distribution. Most people are never tested, those who are tested are generally tested only as a diagnostic tool indicated by adverse symptoms, if the testing technology and medical expertise are even available. This is a biased sample, and not even all of these results have been well recorded or sampled worldwide throughout history to reveal trends in symptom presentation, medical testing practice, technology diffusion, or actual end stage renal disease prevalence. That would be interesting, and useful in policy and medical practice standard development, even if it didn't reveal the normal distribution of GFR in the unsampled, healthy or untreated majority of the population.